#DrugTarget
🦠 New #DrugCandidate targets for #tuberculosis? Dos Santos Silva and Dias review #structure, physiological role and medical potential of the #Mycobacterium superfamily of cell wall hydrolases NlpC_60.

➡️ doi.org/10.1002/1873-3468.70021

#bacteria #microbiology #drugtarget
April 24, 2025 at 11:03 AM
The methylcitrate cycle (MCC) – a lesser-known cousin of the TCA cycle – plays a key role in pathogenic fungi & bacteria. 🦠✨ Absent in humans, Korn and colleagues @uni-jena.de‬ highlight its potential as a new #DrugTarget & #biotech tool. #Microsky
buff.ly/TZNGfZS
June 15, 2025 at 6:01 AM
Take your drug development pipeline to the next level with Delta4’s AI-powered platform!

💡 Accelerate Efficiency & Speed
✅ Boost Success Rates
🔍 Ensure Transparency
🧬 Gain Valuable Biomarker Insights

Learn more here:
delta4.ai/development-...

#Delta4 #DrugDiscovery #DrugTarget #DrugRepositioning
May 30, 2025 at 9:22 AM
Lisa wollte immer nur forschen. Doch als sie ein vielversprechendes #DrugTarget entdeckt, lässt sie der Gedanke nicht mehr los, ein #Startup zu gründen. Und so beginnt ihr Weg durch Patentanmeldung, Finanzierungshürden und Partnersuche… Die ganze Geschichte unter: www.laborjournal.de/rubric/essay...
July 22, 2025 at 7:58 AM
Clonal hematopoiesis (CH) is the age-related expansion of mutated blood stem cell clones that increases the risk of blood cancer. A recent publication shows that #IL1RAP isn’t just a marker of CH, it appears to drive it.

lnkd.in/eaCzJUwM

#ClonalHematopoiesis #AML #DrugTarget #CancerPrevention
lnkd.in
October 3, 2025 at 2:07 PM